Target HER Four in Breast Cancer?

Oncotarget - United States
doi 10.18632/oncotarget.26867
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Serum HER-2 Concentration in Patients With Primary Breast Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer

PLoS ONE
Multidisciplinary
2016English

Hormone Receptors, Her-2/Neu and Chromosomal Aberrations in Breast Cancer

Medical Journal Armed Forces India
Medicine
2008English

Are We HER-ting for Innovation in Neoadjuvant Breast Cancer Trial Design?

Breast Cancer Research
Cancer ResearchOncology
2009English

Polyamine Analogues as Novel Anti-Her Family Agents in Human Breast Cancer

2008English

Intratumoral Heterogeneity of HER-2 Gene Amplification and Protein Overexpression in Breast Cancer

Human Pathology
Forensic MedicinePathology
2010English

Are We Missing the mTOR Target in Breast Cancer?

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Skp2 Is a Promising Therapeutic Target in Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2012English

Rhodesia and Her Four Discriminatory Constitutions

Présence Africaine
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy